We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of Phosphodiesterase Type 5 Inhibitor Treatment on the Rates of Sexually Transmitted Diseases in a Veterans Affairs Medical Center Patient Population.
- Authors
Corbo, Jason M.; Brown, Jamie N.; Bryan, William E.; Townsend, Mary L.
- Abstract
The article focuses on study of relationship between phosphodiesterase type 5 (PDE5) inhibitor and sexually transmitted diseases (STDs) in veteran population. It highlights that PDE5 inhibitors promote the vasodilation mechanism in the treatment of erectile dysfunction. As per the study conducted in Veterans Affairs Medical Center (VAMC) it suggested that PDE5 inhibitors do not increase the risk of STDs in VAMC patient population.
- Subjects
PHOSPHODIESTERASE inhibitors; EPIDEMIOLOGY of sexually transmitted diseases; CHI-squared test; CHLAMYDIA infections; GONORRHEA; HIV infections; LONGITUDINAL method; STATISTICAL sampling; SYPHILIS; VETERANS' hospitals; RETROSPECTIVE studies; DATA analysis software; DESCRIPTIVE statistics; THERAPEUTICS
- Publication
Journal of Pharmacy Practice, 2014, Vol 27, Issue 1, p40
- ISSN
0897-1900
- Publication type
Journal Article
- DOI
10.1177/0897190013504956